A safranin–diurea bridged hybrid mesoporous organosilica (SDU–HMS) was synthesized for simultaneous diagnosis and therapy. This study assessed the impact of integrated functional units on drug loading/release and imaging. The drug delivery efficiency and biocompatibility of the red fluorescent SDU–HMS carrier was evaluated experimentally.